10.3390/nu11092205 31 BauersfeldS
Nausea, vomiting, diarrhea, reflux and constipation are common, due to the activation of GLP-1 receptors in the gut
Distinctions in Side Effects Although the side effects are largely similar, some research suggests that Tirzepatide may result in fewer severe gastrointestinal side effects compared to Semaglutide
[2] Several postmarketing reports of pancreatitis (some fatal) have been made in people treated with sitagliptin and other DPP-4 inhibitors, [23] [24] and the US FDA package insert carries a warning to this effect, [2] although the causal link between sitagliptin and pancreatitis has not yet been fully substantiated
This is particularly beneficial for individuals with compromised liver function or those seeking rapid detoxification support
This is not the position depicted in Figure 1 , which instead seeks to understand the increased frequency of CFTR mutation(s), with or without mutation in SPINK1 , among patients with idiopathic chronic pancreatitis (97), especially the tropical variant (102)